EIAV减毒疫苗减毒机制及免疫研究进展
被引量:1
出处
《细胞与分子免疫学杂志》
CAS
CSCD
北大核心
2008年第12期1216-1218,共3页
Chinese Journal of Cellular and Molecular Immunology
基金
国家自然科学基金资助项目(30671941)
参考文献20
-
1Kono Y, Hirasawa K, Fukunaga Y, et al. Recrudescence of Equine infectious anemia virus by treatment with immunosuppressive drugs [ J]. Natl Inst Anita Health Q (Tokyo), 1976, 16( 1 ) : 8 - 15.
-
2Shen RX, Wang ZY, Dong JP, et al. Fetal donkey dermal ceils adapted attenuated vaccine of equine infectious anemia virus and its culture method (Chinese patent No. 01123620). China, 2001.
-
3Shen RX, Xu ZD, He XS, et al. Study on immunological methods of equine infectious mlemia[J]. China Agric Sci, 1979 : 41 - 115.
-
4Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF- 1 is the ligand for LESTR/fusin and prevents infection by T-cell-lineadapted HIV-1 [J]. Nature, 1996, 382(6594) : 833 -835.
-
5Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4^+ cells is mediated by the chemokine receptor CC-CKR-5 [ J]. Nature, 1996, 381 (6584) : 667 -673.
-
6Meng QL, Li SW, Liu LX, et al. Characterization of cytoplasmic tail truncated envelop proteins of Equine infectious anemia virus in vitro [J]. Virus Research, 2008, 133(2) : 201 -210.
-
7Liang H, He X, Shen T, et al. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV [ J]. Arch virol, 2006, 151 (7): 1387 - 1403.
-
8Shen T, Liang H, Tong X, et al. Amino acid mutations of an infectious clone of Chinese EIAV attenuated vaccine resulted in reversion of virulence[ J]. Vaacine, 2006, 24 (6) : 738 - 749.
-
9Tu YB, Zhou T, Yuan XF, et al. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus [ J ]. Arch Virol, 2007, 152(1): 209-218.
-
10Maury W, Thompson R J, Jones Q, et al. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism[J]. J Virol, 2005, 79(9): 5653-5664.
二级参考文献6
-
1代春铭,张晓燕,张然然,邵一鸣,沈荣显.重组杆状病毒表达的EIAVEnv蛋白与含有env基因重组痘苗病毒的联合免疫[J].细胞与分子免疫学杂志,2004,20(4):410-414. 被引量:2
-
2梁华,沈弢,张晓燕,邵一鸣.马传染性贫血病毒基因表达调节机制的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):130-132. 被引量:2
-
3Hammond SA,Cook SJ,Lichtenstein DL,et al.Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process[J].J Virol,1997,71(5):3840-3852.
-
4McGuire TC,Fraser DG,Mealey RH.Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus[J].Viral Immunol,2002,15(4),521-531.
-
5Chung C,Mealey RH,McGuire TC.CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins[J].Virology,2004,327(1):144-154.
-
6沈荣显 徐振东 等.马传染性贫血免疫的研究[J].中国农业科学,1979,(4):1-15.
共引文献4
-
1王盈,张晓燕,魏丽丽,吴东来,相文华,王晓钧,吕晓玲,沈荣显,邵一鸣.EIAV减毒疫苗诱导马外周血单个核细胞Th1型细胞因子的转录[J].中国免疫学杂志,2007,23(8):709-713. 被引量:1
-
2王建新,王敏,刘新奇.EIAV强毒株和疫苗株gp45的纯化及结晶比较[J].天津科技大学学报,2011,26(4):10-13. 被引量:1
-
3杨冰,叶元,周英琼.子宫内膜癌雌孕激素受体及P^(53)表达的临床意义[J].广西医科大学学报,2000,17(2):225-226. 被引量:2
-
4王雪峰,张相敏,林跃智,杜承,王晓钧.马传染性贫血病毒弱毒疫苗致弱及免疫保护机制研究进展[J].生命科学,2021,33(1):26-35.
同被引文献15
-
1梁华,沈弢,张晓燕,邵一鸣.马传染性贫血病毒基因表达调节机制的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):130-132. 被引量:2
-
2张晓燕,李红梅,梁华,沈弢,马燕,相文华,沈荣显,邵一鸣.EIAV减毒疫苗诱导的特异性细胞免疫应答[J].细胞与分子免疫学杂志,2006,22(1):115-118. 被引量:5
-
3沈荣显.马传染性贫血病免疫的研究[J].中国农业科学,1979,(4):1-15.
-
4Chan D C, Fass D, Berger J M, et al. Core structure of gp41 from the HIV envelope glycoprotein[J]. Cell, 1997,89: 263-273.
-
5Tan K, Liu J, Wang J H, et al. Atomic structure of a thermostable subdomain of HIV-1 gp41 [J]. Proc Natl Acad Sci USA, 1997,94 (23) : 12303-12308.
-
6Weissenhorn W, Dessen A, Harrison S C, et al. Atomic structure of the ectodomain from HIV-1 gp41[J]. Nature, 1997,387 (6631) : 426-430.
-
7Home W S, Johnson L M, Ketas T J, et al. Structural and biological mimicry of protein surface recognition by al- pha/beta-peptide foldamers[J]. Proc Natl Acad Sci USA, 2009, 106 (35) : 14751-14756.
-
8Buzon V, Natrajan G, Schibli D, et al. Crystal structure of HIV-1 gp41 including both fusion peptide and mem- brane proximal external regions [J]. Plos Pathog, 2010, 6 (5) : 880.
-
9Luftig M A, Mattu M, Di Giovine P, et al. Structural basis for HIV-1 neutralization by a gp41 fusion interme- diate-directed antibody[J]. Nat Struct Mol Biol, 2006, 13 (8) : 740-747.
-
10Kwong P D, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J]. Na- ture, 1998,393 (6686) : 648-659.
-
1王盈,魏丽丽,相文华,沈荣显.EIAV与HIV分子生物学相关性研究进展[J].中国生物工程杂志,2004,24(5):5-9. 被引量:3
-
2汪南平,刘辅仁,李世荫.表皮免疫研究进展[J].中国皮肤性病学杂志,1993,7(2):116-118. 被引量:1
-
3梁华,张晓燕,沈弢,童骁,马燕,李红梅,相文华,沈荣显,邵一鸣.实时定量PCR检测马传染性贫血病毒载量方法的建立和应用[J].中华微生物学和免疫学杂志,2005,25(12):1035-1039.
-
4郑波慧,廖小梅.第三代慢病毒载体的研究进展及其在急性白血病基因治疗中的运用[J].华西医学,2008,23(3):661-662. 被引量:1
-
5王淑兰,王安民,杨畔农.马属动物驴“脾气虚”证的实验研究[J].中医杂志,1990,31(3):49-51. 被引量:26
-
6梁华,沈弢,张晓燕,邵一鸣.马传染性贫血病毒基因表达调节机制的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):130-132. 被引量:2
-
7周红超,张景霞.丙型肝炎病毒特异性细胞免疫研究进展[J].国外医学(病毒学分册),1996,3(4):100-103.
-
8史瑞明,雷春莲.肺炎支原体感染免疫研究进展[J].国外医学(妇幼保健分册),2002,13(2):94-96. 被引量:95
-
9韦浩,陈春美,杨卫忠.调节性T细胞与胶质瘤免疫研究进展[J].国际神经病学神经外科学杂志,2011,38(6):605-606. 被引量:4
-
10中专家指出艾滋病疫苗研制应该“两条腿”走路[J].传染病网络动态,2003(5):10-10.